Global Oligonucleotide Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Antisense Oligonucleotides (ASO)
1.2.3 siRNA
1.2.4 mRNA
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Neuromuscular Diseases
1.3.3 hATTR
1.3.4 COVID-19
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Oligonucleotide Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Oligonucleotide Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Oligonucleotide Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Oligonucleotide Therapeutics Market Size and Prospective (2020-2031)
2.5.3 Japan Oligonucleotide Therapeutics Market Size and Prospective (2020-2031)
2.5.4 China Oligonucleotide Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Oligonucleotide Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Oligonucleotide Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Oligonucleotide Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Oligonucleotide Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Oligonucleotide Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Oligonucleotide Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Oligonucleotide Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Oligonucleotide Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Oligonucleotide Therapeutics Revenue
5.4 Global Oligonucleotide Therapeutics Market Concentration Analysis
5.4.1 Global Oligonucleotide Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Therapeutics Revenue in 2024
5.5 Global Key Players of Oligonucleotide Therapeutics Head office and Area Served
5.6 Global Key Players of Oligonucleotide Therapeutics, Product and Application
5.7 Global Key Players of Oligonucleotide Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Oligonucleotide Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Oligonucleotide Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Oligonucleotide Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Oligonucleotide Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Oligonucleotide Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Oligonucleotide Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Oligonucleotide Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Oligonucleotide Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Oligonucleotide Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Oligonucleotide Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Japan Market: Players, Segments and Downstream
6.3.1 Japan Oligonucleotide Therapeutics Revenue by Company (2020-2025)
6.3.2 Japan Market Size by Type
6.3.2.1 Japan Oligonucleotide Therapeutics Market Size by Type (2020-2025)
6.3.2.2 Japan Oligonucleotide Therapeutics Market Share by Type (2020-2025)
6.3.3 Japan Market Size by Application
6.3.3.1 Japan Oligonucleotide Therapeutics Market Size by Application (2020-2025)
6.3.3.2 Japan Oligonucleotide Therapeutics Market Share by Application (2020-2025)
6.3.4 Japan Market Trend and Opportunities
6.4 China Market: Players, Segments and Downstream
6.4.1 China Oligonucleotide Therapeutics Revenue by Company (2020-2025)
6.4.2 China Market Size by Type
6.4.2.1 China Oligonucleotide Therapeutics Market Size by Type (2020-2025)
6.4.2.2 China Oligonucleotide Therapeutics Market Share by Type (2020-2025)
6.4.3 China Market Size by Application
6.4.3.1 China Oligonucleotide Therapeutics Market Size by Application (2020-2025)
6.4.3.2 China Oligonucleotide Therapeutics Market Share by Application (2020-2025)
6.4.4 China Market Trend and Opportunities
7 Key Players Profiles
7.1 Sarepta Therapeutics
7.1.1 Sarepta Therapeutics Company Details
7.1.2 Sarepta Therapeutics Business Overview
7.1.3 Sarepta Therapeutics Oligonucleotide Therapeutics Introduction
7.1.4 Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.1.5 Sarepta Therapeutics Recent Development
7.2 Ionis Pharmaceuticals
7.2.1 Ionis Pharmaceuticals Company Details
7.2.2 Ionis Pharmaceuticals Business Overview
7.2.3 Ionis Pharmaceuticals Oligonucleotide Therapeutics Introduction
7.2.4 Ionis Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.2.5 Ionis Pharmaceuticals Recent Development
7.3 Alnylam
7.3.1 Alnylam Company Details
7.3.2 Alnylam Business Overview
7.3.3 Alnylam Oligonucleotide Therapeutics Introduction
7.3.4 Alnylam Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.3.5 Alnylam Recent Development
7.4 Biogen
7.4.1 Biogen Company Details
7.4.2 Biogen Business Overview
7.4.3 Biogen Oligonucleotide Therapeutics Introduction
7.4.4 Biogen Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.4.5 Biogen Recent Development
7.5 Nippon Shinyaku
7.5.1 Nippon Shinyaku Company Details
7.5.2 Nippon Shinyaku Business Overview
7.5.3 Nippon Shinyaku Oligonucleotide Therapeutics Introduction
7.5.4 Nippon Shinyaku Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.5.5 Nippon Shinyaku Recent Development
7.6 Sobi
7.6.1 Sobi Company Details
7.6.2 Sobi Business Overview
7.6.3 Sobi Oligonucleotide Therapeutics Introduction
7.6.4 Sobi Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.6.5 Sobi Recent Development
7.7 Novartis
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Oligonucleotide Therapeutics Introduction
7.7.4 Novartis Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.7.5 Novartis Recent Development
7.8 BioNTech
7.8.1 BioNTech Company Details
7.8.2 BioNTech Business Overview
7.8.3 BioNTech Oligonucleotide Therapeutics Introduction
7.8.4 BioNTech Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.8.5 BioNTech Recent Development
7.9 Pfizer
7.9.1 Pfizer Company Details
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Oligonucleotide Therapeutics Introduction
7.9.4 Pfizer Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.9.5 Pfizer Recent Development
7.10 Moderna Therapeutics
7.10.1 Moderna Therapeutics Company Details
7.10.2 Moderna Therapeutics Business Overview
7.10.3 Moderna Therapeutics Oligonucleotide Therapeutics Introduction
7.10.4 Moderna Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.10.5 Moderna Therapeutics Recent Development
7.11 Jazz Pharmaceuticals
7.11.1 Jazz Pharmaceuticals Company Details
7.11.2 Jazz Pharmaceuticals Business Overview
7.11.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Introduction
7.11.4 Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.11.5 Jazz Pharmaceuticals Recent Development
7.12 CureVac
7.12.1 CureVac Company Details
7.12.2 CureVac Business Overview
7.12.3 CureVac Oligonucleotide Therapeutics Introduction
7.12.4 CureVac Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.12.5 CureVac Recent Development
7.13 Regulus Therapeutics
7.13.1 Regulus Therapeutics Company Details
7.13.2 Regulus Therapeutics Business Overview
7.13.3 Regulus Therapeutics Oligonucleotide Therapeutics Introduction
7.13.4 Regulus Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.13.5 Regulus Therapeutics Recent Development
7.14 ProQR
7.14.1 ProQR Company Details
7.14.2 ProQR Business Overview
7.14.3 ProQR Oligonucleotide Therapeutics Introduction
7.14.4 ProQR Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.14.5 ProQR Recent Development
7.15 Secarna
7.15.1 Secarna Company Details
7.15.2 Secarna Business Overview
7.15.3 Secarna Oligonucleotide Therapeutics Introduction
7.15.4 Secarna Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.15.5 Secarna Recent Development
7.16 MiNA Therapeutics
7.16.1 MiNA Therapeutics Company Details
7.16.2 MiNA Therapeutics Business Overview
7.16.3 MiNA Therapeutics Oligonucleotide Therapeutics Introduction
7.16.4 MiNA Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.16.5 MiNA Therapeutics Recent Development
7.17 Sylentis
7.17.1 Sylentis Company Details
7.17.2 Sylentis Business Overview
7.17.3 Sylentis Oligonucleotide Therapeutics Introduction
7.17.4 Sylentis Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.17.5 Sylentis Recent Development
7.18 Arrowhead
7.18.1 Arrowhead Company Details
7.18.2 Arrowhead Business Overview
7.18.3 Arrowhead Oligonucleotide Therapeutics Introduction
7.18.4 Arrowhead Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.18.5 Arrowhead Recent Development
7.19 Silence Therapeutics
7.19.1 Silence Therapeutics Company Details
7.19.2 Silence Therapeutics Business Overview
7.19.3 Silence Therapeutics Oligonucleotide Therapeutics Introduction
7.19.4 Silence Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.19.5 Silence Therapeutics Recent Development
7.20 Dicerna
7.20.1 Dicerna Company Details
7.20.2 Dicerna Business Overview
7.20.3 Dicerna Oligonucleotide Therapeutics Introduction
7.20.4 Dicerna Revenue in Oligonucleotide Therapeutics Business (2020-2025)
7.20.5 Dicerna Recent Development
8 Oligonucleotide Therapeutics Market Dynamics
8.1 Oligonucleotide Therapeutics Industry Trends
8.2 Oligonucleotide Therapeutics Market Drivers
8.3 Oligonucleotide Therapeutics Market Challenges
8.4 Oligonucleotide Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Global Oligonucleotide Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Oligonucleotide Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Oligonucleotide Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Oligonucleotide Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Oligonucleotide Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Oligonucleotide Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Oligonucleotide Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Oligonucleotide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Oligonucleotide Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Oligonucleotide Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Oligonucleotide Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Oligonucleotide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Oligonucleotide Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Oligonucleotide Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Oligonucleotide Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Oligonucleotide Therapeutics Application
Table 18. Global Oligonucleotide Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Oligonucleotide Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Oligonucleotide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics as of 2024)
Table 21. Ranking of Global Top Oligonucleotide Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Oligonucleotide Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Oligonucleotide Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Oligonucleotide Therapeutics, Product and Application
Table 25. Global Key Players of Oligonucleotide Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Oligonucleotide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Oligonucleotide Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Oligonucleotide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Oligonucleotide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Oligonucleotide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Oligonucleotide Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Oligonucleotide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Oligonucleotide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. Japan Oligonucleotide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. Japan Oligonucleotide Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. Japan Oligonucleotide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. Japan Oligonucleotide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. China Oligonucleotide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. China Oligonucleotide Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. China Oligonucleotide Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. China Oligonucleotide Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Sarepta Therapeutics Company Details
Table 44. Sarepta Therapeutics Business Overview
Table 45. Sarepta Therapeutics Oligonucleotide Therapeutics Product
Table 46. Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 47. Sarepta Therapeutics Recent Development
Table 48. Ionis Pharmaceuticals Company Details
Table 49. Ionis Pharmaceuticals Business Overview
Table 50. Ionis Pharmaceuticals Oligonucleotide Therapeutics Product
Table 51. Ionis Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 52. Ionis Pharmaceuticals Recent Development
Table 53. Alnylam Company Details
Table 54. Alnylam Business Overview
Table 55. Alnylam Oligonucleotide Therapeutics Product
Table 56. Alnylam Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 57. Alnylam Recent Development
Table 58. Biogen Company Details
Table 59. Biogen Business Overview
Table 60. Biogen Oligonucleotide Therapeutics Product
Table 61. Biogen Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 62. Biogen Recent Development
Table 63. Nippon Shinyaku Company Details
Table 64. Nippon Shinyaku Business Overview
Table 65. Nippon Shinyaku Oligonucleotide Therapeutics Product
Table 66. Nippon Shinyaku Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 67. Nippon Shinyaku Recent Development
Table 68. Sobi Company Details
Table 69. Sobi Business Overview
Table 70. Sobi Oligonucleotide Therapeutics Product
Table 71. Sobi Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 72. Sobi Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Oligonucleotide Therapeutics Product
Table 76. Novartis Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. BioNTech Company Details
Table 79. BioNTech Business Overview
Table 80. BioNTech Oligonucleotide Therapeutics Product
Table 81. BioNTech Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 82. BioNTech Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Oligonucleotide Therapeutics Product
Table 86. Pfizer Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Moderna Therapeutics Company Details
Table 89. Moderna Therapeutics Business Overview
Table 90. Moderna Therapeutics Oligonucleotide Therapeutics Product
Table 91. Moderna Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 92. Moderna Therapeutics Recent Development
Table 93. Jazz Pharmaceuticals Company Details
Table 94. Jazz Pharmaceuticals Business Overview
Table 95. Jazz Pharmaceuticals Oligonucleotide Therapeutics Product
Table 96. Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 97. Jazz Pharmaceuticals Recent Development
Table 98. CureVac Company Details
Table 99. CureVac Business Overview
Table 100. CureVac Oligonucleotide Therapeutics Product
Table 101. CureVac Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 102. CureVac Recent Development
Table 103. Regulus Therapeutics Company Details
Table 104. Regulus Therapeutics Business Overview
Table 105. Regulus Therapeutics Oligonucleotide Therapeutics Product
Table 106. Regulus Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 107. Regulus Therapeutics Recent Development
Table 108. ProQR Company Details
Table 109. ProQR Business Overview
Table 110. ProQR Oligonucleotide Therapeutics Product
Table 111. ProQR Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 112. ProQR Recent Development
Table 113. Secarna Company Details
Table 114. Secarna Business Overview
Table 115. Secarna Oligonucleotide Therapeutics Product
Table 116. Secarna Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 117. Secarna Recent Development
Table 118. MiNA Therapeutics Company Details
Table 119. MiNA Therapeutics Business Overview
Table 120. MiNA Therapeutics Oligonucleotide Therapeutics Product
Table 121. MiNA Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 122. MiNA Therapeutics Recent Development
Table 123. Sylentis Company Details
Table 124. Sylentis Business Overview
Table 125. Sylentis Oligonucleotide Therapeutics Product
Table 126. Sylentis Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 127. Sylentis Recent Development
Table 128. Arrowhead Company Details
Table 129. Arrowhead Business Overview
Table 130. Arrowhead Oligonucleotide Therapeutics Product
Table 131. Arrowhead Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 132. Arrowhead Recent Development
Table 133. Silence Therapeutics Company Details
Table 134. Silence Therapeutics Business Overview
Table 135. Silence Therapeutics Oligonucleotide Therapeutics Product
Table 136. Silence Therapeutics Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 137. Silence Therapeutics Recent Development
Table 138. Dicerna Company Details
Table 139. Dicerna Business Overview
Table 140. Dicerna Oligonucleotide Therapeutics Product
Table 141. Dicerna Revenue in Oligonucleotide Therapeutics Business (2020-2025) & (US$ Million)
Table 142. Dicerna Recent Development
Table 143. Oligonucleotide Therapeutics Market Trends
Table 144. Oligonucleotide Therapeutics Market Drivers
Table 145. Oligonucleotide Therapeutics Market Challenges
Table 146. Oligonucleotide Therapeutics Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources


List of Figures
Figure 1. Oligonucleotide Therapeutics Product Picture
Figure 2. Global Oligonucleotide Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Antisense Oligonucleotides (ASO) Features
Figure 4. siRNA Features
Figure 5. mRNA Features
Figure 6. Global Oligonucleotide Therapeutics Market Share by Application: 2024 VS 2031
Figure 7. Neuromuscular Diseases
Figure 8. hATTR
Figure 9. COVID-19
Figure 10. Other
Figure 11. Oligonucleotide Therapeutics Report Years Considered
Figure 12. Global Oligonucleotide Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Oligonucleotide Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oligonucleotide Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Oligonucleotide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Oligonucleotide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Oligonucleotide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Oligonucleotide Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Oligonucleotide Therapeutics Market Share by Players in 2024
Figure 20. Global Top Oligonucleotide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapeutics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Oligonucleotide Therapeutics Revenue in 2024
Figure 22. North America Oligonucleotide Therapeutics Market Share by Type (2020-2025)
Figure 23. North America Oligonucleotide Therapeutics Market Share by Application (2020-2025)
Figure 24. Europe Oligonucleotide Therapeutics Market Share by Type (2020-2025)
Figure 25. Europe Oligonucleotide Therapeutics Market Share by Application (2020-2025)
Figure 26. Japan Oligonucleotide Therapeutics Market Share by Type (2020-2025)
Figure 27. Japan Oligonucleotide Therapeutics Market Share by Application (2020-2025)
Figure 28. China Oligonucleotide Therapeutics Market Share by Type (2020-2025)
Figure 29. China Oligonucleotide Therapeutics Market Share by Application (2020-2025)
Figure 30. Sarepta Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 31. Ionis Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 32. Alnylam Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 33. Biogen Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 34. Nippon Shinyaku Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 35. Sobi Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 36. Novartis Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 37. BioNTech Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 38. Pfizer Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 39. Moderna Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 40. Jazz Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 41. CureVac Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 42. Regulus Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 43. ProQR Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 44. Secarna Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 45. MiNA Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 46. Sylentis Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 47. Arrowhead Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 48. Silence Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 49. Dicerna Revenue Growth Rate in Oligonucleotide Therapeutics Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit